Results 11 to 20 of about 518,832 (292)
Breath Biomarkers in Diagnostic Applications [PDF]
Molecules, 2021 The detection of chemical compounds in exhaled human breath presents an opportunity to determine physiological state, diagnose disease or assess environmental exposure. Recent advancements in metabolomics research have led to improved capabilities to explore human metabolic profiles in breath.
Y Lan Pham, Jonathan Beauchamp
openaire +3 more sources
Diagnostic Biomarkers of Epilepsy [PDF]
Current Pharmaceutical Biotechnology, 2018 Diagnostic biomarkers of epilepsy are objectively measurable variables associated with the development of epilepsy or the propensity to generate seizures. Identification of biomarkers could be helpful for differential diagnosis and for tailored therapeutic approaches.This review focuses on diagnostic biomarkers of epilepsy, including genetic ...
Sueri C +15 more
openaire +4 more sources
Diagnostic Biomarkers of Dilated Cardiomyopathy
Immunobiology, 2021 Background: Dilated cardiomyopathy (DCM) is a condition involving dilation of cardiac chambers, which results in contraction impairment. Besides invasive and non-invasive diagnostic procedures, cardiac biomarkers are of great importance in both diagnosis and prognosis of the disease.
Aysan Moeinafshar +2 more
openaire +2 more sources
Novel Diagnostic Biomarkers in Colorectal Cancer [PDF]
International Journal of Molecular Sciences, 2022 Colorectal cancer (CRC) is still a leading cause of cancer death worldwide. Less than half of cases are diagnosed when the cancer is locally advanced. CRC is a heterogenous disease associated with a number of genetic or somatic mutations. Diagnostic markers are used for risk stratification and early detection, which might prolong overall survival ...
Aneta L. Zygulska, Piotr Pierzchalski
openaire +3 more sources
Potential diagnostic biomarkers for schizophrenia
Medical Review, 2022 Abstract Schizophrenia (SCH) is a complex and severe mental disorder with high prevalence, disability, mortality and carries a heavy disease burden, the lifetime prevalence of SCH is around 0.7%–1.0%, which has a profound impact on the individual and society.
Weihua Yue, Hailiang Huang, Jubao Duan
openaire +3 more sources
Blood Biomarkers: Democratizing Alzheimer’s Diagnostics
Neuron, 2020 Currently available biomarkers for Alzheimer's disease are of limited availability due to high costs and perceived invasiveness. New studies reveal that Alzheimer's pathologies now can be reliably quantified in vivo using regular blood tests.
Zetterberg, H, Blennow, K
openaire +3 more sources
Diagnostic biomarker for ACTN1 macrothrombocytopenia [PDF]
Blood, 2015 To the editor: Congenital macrothrombocytopenia is a heterogeneous group of rare disorders characterized by abnormally giant platelets and thrombocytopenia with a variable degree of bleeding tendency.[1][1],[2][2] A definitive diagnosis is possible in only approximately half of the patients ...
Shinji, Kunishima +3 more
openaire +2 more sources
Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer [PDF]
PeerJBackground Cell division cycle protein 45 (CDC45) has been demonstrated to play vital roles in the progression of various malignancies. However, the clinical significance of CDC45 in gastric cancer (GC) remains unreported.
Lihua Wu +8 more
doaj +2 more sources
Cancer Reports, 2021 Background Colorectal cancer is one of the most common cancers and the leading cause of cancer‐related death worldwide. Early diagnostic methods help in therapeutic success and higher survival rate.
Shaymaa Abdelraheem Abdelhady +3 more
doaj +1 more source
Addressing the needs of traumatic brain injury with clinical proteomics. [PDF]
, 2014 BackgroundNeurotrauma or injuries to the central nervous system (CNS) are a serious public health problem worldwide. Approximately 75% of all traumatic brain injuries (TBIs) are concussions or other mild TBI (mTBI) forms.
Loo, Joseph A +3 more
core +1 more source